What are the differential diagnoses and management plan for a patient presenting with a unilateral intranasal septal ulcer that has not responded to conservative measures, with no history of smoking or drug use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Unilateral Intranasal Septal Ulcer: Differential Diagnosis and Management Plan

For a unilateral nasal septal ulcer unresponsive to conservative treatment in a non-smoker without drug use history, you must pursue tissue biopsy with ANCA and ACE testing to exclude Wegener's granulomatosis, sarcoidosis, and malignancy before considering the diagnosis idiopathic. 1, 2

Differential Diagnoses (Prioritized by Clinical Significance)

Granulomatous/Autoimmune Disease (Most Critical to Exclude)

  • Wegener's granulomatosis (Granulomatosis with polyangiitis): Unilateral presentation is common, and patients often present with nasal obstruction rather than epistaxis 2
  • Sarcoidosis: Can present with nasal septal ulceration and granulomatous inflammation 1, 2
  • Midline granuloma: Associated with destructive nasal lesions 1

Infectious Etiologies

  • Leishmaniasis: Anterior nasal septum is the most commonly involved area in New World mucosal leishmaniasis; perforation may be palpated and visualized 1
  • Tuberculosis: Presents with stellate ulcers with undermined edges 1
  • Invasive fungal infection: Consider in immunocompromised patients; lesions may appear brick red or black necrotic areas 1

Neoplastic Disease

  • Nasal malignancies: Present with unilateral nasal obstruction (66.7%) and epistaxis (55%); may not be visible on anterior rhinoscopy alone 1
  • Inverted papilloma: Characterized by polypoid appearance and unilateral location 1

Other Causes

  • Trigeminal trophic syndrome: Characterized by trigeminal anesthesia, nasal alar ulceration, and facial paresthesia; appearance after trigeminal ablation is diagnostic 3
  • Factitious disorder: Self-induced lesions with normal trigeminal function and patient denial of manipulation 3
  • Idiopathic: Diagnosis of exclusion (47% of cases in one series) 2

Diagnostic Work-Up Algorithm

Step 1: Pre-Biopsy Blood Work (Mandatory)

Before proceeding with biopsy, obtain the following to exclude contraindications and provide diagnostic clues 1:

  • Complete blood count: Rule out anemia, leukemia, or other hematologic disorders 1
  • Coagulation studies: Exclude bleeding diathesis before biopsy 1
  • Fasting blood glucose: Hyperglycemia predisposes to invasive fungal infection 1
  • HIV antibody and syphilis serology: Rule out infectious causes 1
  • ANCA (anti-neutrophil cytoplasmic antibody): Successfully identifies Wegener's granulomatosis 2
  • ACE (angiotensin converting enzyme): Supports diagnosis of sarcoidosis 2
  • ESR and CRP: Limited diagnostic value but may support inflammatory conditions 2

Step 2: Nasal Endoscopy (Essential for Unilateral Disease)

Perform nasal endoscopy to examine the entire nasal cavity and nasopharynx, as unilateral lesions may harbor malignancy not visible on anterior rhinoscopy. 1

  • Nasal endoscopy is specifically recommended for recurrent unilateral nasal bleeding or when concern exists for unrecognized pathology 1
  • Examine for posterior nasal cavity and nasopharyngeal masses that may present with epistaxis 1
  • Look for brick red or black necrotic areas suggestive of invasive fungal disease 1

Step 3: Tissue Biopsy (Indicated for Ulcers >2 Weeks or Treatment-Refractory)

Biopsy should be performed for oral/nasal ulceration persisting over 2 weeks or not responding to 1-2 weeks of treatment. 1

Critical caveat: In a retrospective study of 74 patients with septal perforation/ulcer, biopsy showed non-specific findings in 55% of cases and only contributed to diagnosis when ANCA/ACE were abnormal or malignancy was suspected 2

  • Biopsy technique: Obtain adequate tissue from ulcer edge and base 1
  • Send specimens for:
    • Histopathology (H&E staining) 1
    • Fungal staining and culture (if invasive fungal disease suspected) 1
    • Mycobacterial culture (if tuberculosis suspected) 1
    • Leishmania PCR and culture (if endemic area or travel history) 1
    • Immunohistochemistry (if neoplasm suspected) 1

Step 4: Imaging (Selective Use)

  • CT scan: Not routine but indicated for severe disease, immunocompromised state, suspected complications, or before surgery 1
  • MRI: May help differentiate neoplastic from inflammatory disease 1

Management Plan Based on Diagnosis

If ANCA Positive (Wegener's Granulomatosis)

  • Refer to rheumatology immediately for immunosuppressive therapy 2
  • Biopsy confirms diagnosis but treatment should not be delayed if clinical suspicion is high 1

If ACE Elevated (Sarcoidosis)

  • Biopsy showing non-caseating granulomas supports diagnosis 2
  • Refer to pulmonology for systemic evaluation and treatment 1

If Leishmaniasis Confirmed

  • Tissue specimens from nasal septum should be collected by otolaryngologist 1
  • Microscopy, culture, and PCR from tissue specimens 1
  • Refer to infectious disease for systemic antileishmanial therapy 1

If Malignancy Identified

  • Urgent referral to otolaryngology-head and neck surgery 1
  • Staging and multidisciplinary tumor board discussion 1

If Invasive Fungal Disease

  • Immediate biopsy with fungal staining and culture 1
  • Aggressive surgical debridement plus systemic antifungal therapy 1
  • Early diagnosis is critical for prognosis 1

If Idiopathic (Diagnosis of Exclusion)

After excluding all above etiologies with negative ANCA, ACE, biopsy, and cultures 2:

Conservative management:

  • Nasal saline irrigation 2-3 times daily: First-line treatment for moisturization and crust removal 4, 5
  • Avoid topical decongestants: Will further dry nasal mucosa 5
  • Intranasal corticosteroids with caution: May worsen dryness; use lowest effective dose and direct spray away from septum 5
  • Monitor nasal septum periodically: Check for mucosal erosions that may precede perforation 1

Surgical options if conservative measures fail:

  • Extracellular matrix scaffold (MatriStem®): Novel approach showing complete symptom relief in small case series 6
  • Unilateral inferior meatal mucosal flap: Simple technique with good outcomes for perforations up to 26mm 7
  • Septal dermoplasty or flap reconstruction: Traditional approaches but no therapy has demonstrated consistent improvement 6

Common Pitfalls to Avoid

  • Do not assume idiopathic diagnosis without ANCA and ACE testing: These tests successfully identified Wegener's and sarcoidosis when biopsy was non-diagnostic 2
  • Do not rely on biopsy alone: 55% of biopsies show non-specific findings 2
  • Do not miss malignancy: Unilateral lesions require nasal endoscopy as tumors may not be visible on anterior rhinoscopy 1
  • Do not delay biopsy in suspected invasive fungal disease: Early diagnosis is critical for patient prognosis 1
  • Do not prescribe oral antihistamines: Anticholinergic effects worsen nasal dryness 5
  • Avoid surgical reconstruction in factitious disorder: High recurrence rate; psychiatric referral is primary treatment 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The investigation of nasal septal perforations and ulcers.

The Journal of laryngology and otology, 2001

Research

Self-induced nasal ulceration.

Archives of facial plastic surgery, 2004

Guideline

Management of Empty Nose Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Rhinitis Sicca

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Repair of nasal septal perforation using a simple unilateral inferior meatal mucosal flap.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.